Patents by Inventor Steven Hoffman

Steven Hoffman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20200360328
    Abstract: The present invention provides methods for treating cancer.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventor: Steven Hoffman
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER
    Publication number: 20200345753
    Abstract: The present disclosure provides methods, compositions, and kits for treating cancer using a combination of L-rhamnose and a leucine aminopeptidase inhibitor.
    Type: Application
    Filed: July 17, 2020
    Publication date: November 5, 2020
    Inventor: Steven HOFFMAN
  • Compositions and methods for treating autism
    Patent number: 10813901
    Abstract: The invention provides compositions and methods of treating autism. Specifically, the invention relates to treating the core symptoms of autism by administering ?-methyl-DL-tyrosine.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: October 27, 2020
    Assignee: Yamo Pharmaceuticals LLC
    Inventors: Steven Hoffman, John Rothman
  • Transdermal formulations
    Patent number: 10786574
    Abstract: The present disclosure is directed to transdermal and moisturizing compositions.
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: September 29, 2020
    Inventor: Steven Hoffman
  • PERCUTANEOUS ANTI-MICROBIOTA FORMULATIONS
    Publication number: 20200282014
    Abstract: The present disclosure is directed to percutaneous compositions containing an antiseptic, an antibiotic, an antifungal agent, an antihelminth agent, an antiviral agent, or an NSAID.
    Type: Application
    Filed: March 5, 2019
    Publication date: September 10, 2020
    Inventors: Steven Hoffman, John Rothman
  • Compositions and methods for treating autism
    Patent number: 10751313
    Abstract: The invention provides compositions and methods of treating autism. Specifically, the invention relates to treating the core symptoms of autism by administering ?-methyl-DL-tyrosine.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: August 25, 2020
    Assignee: Yamo Pharmaceuticals LLC
    Inventors: Steven Hoffman, John Rothman
  • Pharmaceutical Compositions And Methods
    Publication number: 20200254067
    Abstract: Pharmaceutical compositions and kits including a tyrosine hydroxylase inhibitor; melanin, a melanin promoter, or a combination thereof a p450 3A4 promoter; and a leucine aminopeptidase inhibitor are provided. Also provided are methods of treating cancer in a subject, comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof. Also provided are methods of reducing cell proliferation in a subject comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof.
    Type: Application
    Filed: April 10, 2020
    Publication date: August 13, 2020
    Inventor: Steven Hoffman
  • COMPOSITIONS AND METHODS FOR TREATING ANXIETY-RELATED DISORDERS
    Publication number: 20200246296
    Abstract: The present invention provides methods, compositions, and kits for treating anxiety-related disorders, including OCD and SAD, and for reducing anxiety, obsessive behavior, or compulsive behavior in subjects in need thereof.
    Type: Application
    Filed: January 31, 2020
    Publication date: August 6, 2020
    Inventors: Steven Hoffman, John Rothman
  • Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of Cancer
    Publication number: 20200215082
    Abstract: The present disclosure is directed to methods of treating cancer comprising administering dihydrotestosterone, a dihydrotestosterone derivative, a dihydrotestosterone promoter, or a combination thereof to a patient in need of treatment.
    Type: Application
    Filed: March 19, 2020
    Publication date: July 9, 2020
    Inventor: Steven Hoffman
  • COMPOSITIONS AND METHODS FOR TREATING NERVE AGENT EXPOSURE
    Publication number: 20200163952
    Abstract: The present disclosure is directed to transdermal compositions comprising a poison antidote, and methods of using such compositions to counteract the effects of a poison.
    Type: Application
    Filed: November 26, 2019
    Publication date: May 28, 2020
    Inventor: Steven Hoffman
  • Pharmaceutical compositions and methods
    Patent number: 10646552
    Abstract: Pharmaceutical compositions and kits including a tyrosine hydroxylase inhibitor; melanin, a melanin promoter, or a combination thereof a p450 3A4 promoter; and a leucine aminopeptidase inhibitor are provided. Also provided are methods of treating cancer in a subject, comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof. Also provided are methods of reducing cell proliferation in a subject comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: May 12, 2020
    Assignee: Tyme, Inc.
    Inventor: Steven Hoffman
  • PHARMACEUTICAL COMPOSITIONS AND METHODS
    Publication number: 20200108049
    Abstract: Pharmaceutical compositions and kits including a tyrosine hydroxylase inhibitor; melanin, a melanin promoter, or a combination thereof a p450 3A4 promoter; and a leucine aminopeptidase inhibitor are provided. Also provided are methods of treating cancer in a subject, comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof. Also provided are methods of reducing cell proliferation in a subject comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof.
    Type: Application
    Filed: December 11, 2019
    Publication date: April 9, 2020
    Inventor: Steven Hoffman
  • Compositions And Methods For Treating Intestinal Hyperpermeability
    Publication number: 20200093775
    Abstract: The present invention provides methods, compositions, and kits for treating intestinal hyperpermeability in a subject in need thereof, including conditions such as hyperglycemia and underlying diseases such as diabetes, autism, fibromyalgia, inflammatory bowel disease (IBD), graft versus host disease (GVHD), HIV/AIDS, multiple organ dysfunction syndrome, irritable bowel syndrome (IBS), celiac disease, eczema, psoriasis, acute pancreatitis, Parkinson's disease, depression, chronic fatigue syndrome, asthma, multiple sclerosis, arthritis, ankylosing spondylitis, nonalcoholic fatty liver disease, alcoholic cirrhosis, environmental enteropathy, or kwashiorkor.
    Type: Application
    Filed: November 25, 2019
    Publication date: March 26, 2020
    Inventor: Steven Hoffman
  • Compositions and methods for treating intestinal hyperpermeability
    Patent number: 10517845
    Abstract: The present invention provides methods, compositions, and kits for treating intestinal hyperpermeability in a subject in need thereof, including conditions such as hyperglycemia and underlying diseases such as diabetes, autism, fibromyalgia, inflammatory bowel disease (IBD), graft versus host disease (GVHD), HIV/AIDS, multiple organ dysfunction syndrome, irritable bowel syndrome (IBS), celiac disease, eczema, psoriasis, acute pancreatitis, Parkinson's disease, depression, chronic fatigue syndrome, asthma, multiple sclerosis, arthritis, ankylosing spondylitis, nonalcoholic fatty liver disease, alcoholic cirrhosis, environmental enteropathy, or kwashiorkor.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: December 31, 2019
    Inventor: Steven Hoffman
  • Pharmaceutical compositions and methods
    Patent number: 10507198
    Abstract: Pharmaceutical compositions and kits including a tyrosine hydroxylase inhibitor; melanin, a melanin promoter, or a combination thereof; a p450 3A4 promoter; and a leucine aminopeptidase inhibitor are provided. Also provided are methods of treating cancer in a subject, comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof. Also provided are methods of reducing cell proliferation in a subject comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: December 17, 2019
    Assignee: Tyme, Inc.
    Inventor: Steven Hoffman
  • Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms
    Publication number: 20190298677
    Abstract: The present disclosure is directed to methods, compositions, and kits for treating amyotrophic lateral sclerosis.
    Type: Application
    Filed: June 11, 2019
    Publication date: October 3, 2019
    Inventor: Steven Hoffman
  • Compositions and methods for treating stress-related disorders
    Patent number: 10426836
    Abstract: The present inventions relate generally to compositions, kits, and methods for the treatment of stress-related disorders, including but not limited to post-traumatic stress disorder.
    Type: Grant
    Filed: July 19, 2017
    Date of Patent: October 1, 2019
    Assignee: Hoffman Technologies, Inc.
    Inventor: Steven Hoffman
  • Pharmaceutical Compositions And Methods
    Publication number: 20190275117
    Abstract: Pharmaceutical compositions and kits including a tyrosine hydroxylase inhibitor; melanin, a melanin promoter, or a combination thereof a p450 3A4 promoter; and a leucine aminopeptidase inhibitor are provided. Also provided are methods of treating cancer in a subject, comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof. Also provided are methods of reducing cell proliferation in a subject comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof.
    Type: Application
    Filed: May 23, 2019
    Publication date: September 12, 2019
    Inventor: Steven Hoffman
  • PHARMACEUTICAL COMPOSITIONS AND METHODS
    Publication number: 20190201378
    Abstract: Pharmaceutical compositions and kits including a tyrosine hydroxylase inhibitor; melanin, a melanin promoter, or a combination thereof; a p450 3A4 promoter; and a leucine aminopeptidase inhibitor are provided. Also provided are methods of treating cancer in a subject, comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof. Also provided are methods of reducing cell proliferation in a subject comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof.
    Type: Application
    Filed: March 11, 2019
    Publication date: July 4, 2019
    Inventor: Steven Hoffman
  • TRANSDERMAL FORMULATIONS
    Publication number: 20190192663
    Abstract: The present disclosure is directed to transdermal and moisturizing compositions.
    Type: Application
    Filed: March 5, 2019
    Publication date: June 27, 2019
    Inventor: Steven Hoffman